Protocols · Metabolic
Liraglutide is a once-daily GLP-1 receptor agonist and the first of the acylated analogues to carry a large registered trial record in both type 2 diabetes and obesity. It is a distinct compound from semaglutide: shorter acting, dosed daily rather than weekly, and escalated on a different schedule.
Read this first
Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.
Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.
The escalation step existed to manage gastrointestinal tolerability, which was the dominant reported effect.
Glycaemic endpoints were reported at the lower maintenance figures than those used in obesity work.
Trial material was a ready-made pen solution rather than a lyophilised powder. Where research-grade material is supplied as a powder, the reconstitution calculator on this site converts any vial size and volume.
Open the reconstitution calculatorNo peer-reviewed primary literature reporting administered quantities exists for this item. Anything circulating online about quantities is anecdote rather than evidence, and this page will not reproduce it. The database links below are kept so you can check for yourself as new work is published.
Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.
Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.
